182 related articles for article (PubMed ID: 36375170)
21. Cowpea mosaic virus nanoparticles for cancer imaging and therapy.
Beatty PH; Lewis JD
Adv Drug Deliv Rev; 2019 May; 145():130-144. PubMed ID: 31004625
[TBL] [Abstract][Full Text] [Related]
22. Interaction of Cowpea mosaic virus (CPMV) nanoparticles with antigen presenting cells in vitro and in vivo.
Gonzalez MJ; Plummer EM; Rae CS; Manchester M
PLoS One; 2009 Nov; 4(11):e7981. PubMed ID: 19956734
[TBL] [Abstract][Full Text] [Related]
23. Treatment of Hepatocellular Carcinoma by Multimodal In Situ Vaccination Using Cryoablation and a Plant Virus Immunostimulant.
Ghani MA; Bangar A; Yang Y; Jung E; Sauceda C; Mandt T; Shukla S; Webster NJG; Steinmetz NF; Newton IG
J Vasc Interv Radiol; 2023 Jul; 34(7):1247-1257.e8. PubMed ID: 36997021
[TBL] [Abstract][Full Text] [Related]
24. Differential uptake of chemically modified cowpea mosaic virus nanoparticles in macrophage subpopulations present in inflammatory and tumor microenvironments.
Agrawal A; Manchester M
Biomacromolecules; 2012 Oct; 13(10):3320-6. PubMed ID: 22963597
[TBL] [Abstract][Full Text] [Related]
25. Infusion of imaging and therapeutic molecules into the plant virus-based carrier cowpea mosaic virus: cargo-loading and delivery.
Yildiz I; Lee KL; Chen K; Shukla S; Steinmetz NF
J Control Release; 2013 Dec; 172(2):568-78. PubMed ID: 23665254
[TBL] [Abstract][Full Text] [Related]
26. Injectable Slow-Release Hydrogel Formulation of a Plant Virus-Based COVID-19 Vaccine Candidate.
Nkanga CI; Ortega-Rivera OA; Shin MD; Moreno-Gonzalez MA; Steinmetz NF
Biomacromolecules; 2022 Apr; 23(4):1812-1825. PubMed ID: 35344365
[TBL] [Abstract][Full Text] [Related]
27. Evidence for participation of RNA 1-encoded elicitor in Cowpea mosaic virus-mediated concurrent protection.
Bruening G; Buzayan JM; Ferreiro C; Lim W
Virology; 2000 Jan; 266(2):299-309. PubMed ID: 10639316
[TBL] [Abstract][Full Text] [Related]
28. Inactivated Cowpea Mosaic Virus for In Situ Vaccination: Differential Efficacy of Formalin vs UV-Inactivated Formulations.
Jung E; Mao C; Bhatia M; Koellhoffer EC; Fiering SN; Steinmetz NF
Mol Pharm; 2023 Jan; 20(1):500-507. PubMed ID: 36399598
[TBL] [Abstract][Full Text] [Related]
29. Isolation of Cowpea Mosaic Virus-Binding Peptides.
Chan SK; Steinmetz NF
Biomacromolecules; 2021 Aug; 22(8):3613-3623. PubMed ID: 34314166
[TBL] [Abstract][Full Text] [Related]
30. Interior engineering of a viral nanoparticle and its tumor homing properties.
Wen AM; Shukla S; Saxena P; Aljabali AA; Yildiz I; Dey S; Mealy JE; Yang AC; Evans DJ; Lomonossoff GP; Steinmetz NF
Biomacromolecules; 2012 Dec; 13(12):3990-4001. PubMed ID: 23121655
[TBL] [Abstract][Full Text] [Related]
31. Anti-atherogenic effect of trivalent chromium-loaded CPMV nanoparticles in human aortic smooth muscle cells under hyperglycemic conditions in vitro.
Ganguly R; Wen AM; Myer AB; Czech T; Sahu S; Steinmetz NF; Raman P
Nanoscale; 2016 Mar; 8(12):6542-54. PubMed ID: 26935414
[TBL] [Abstract][Full Text] [Related]
32. Endocytic uptake pathways utilized by CPMV nanoparticles.
Plummer EM; Manchester M
Mol Pharm; 2013 Jan; 10(1):26-32. PubMed ID: 22905759
[TBL] [Abstract][Full Text] [Related]
33. Stability of plant virus-based nanocarriers in gastrointestinal fluids.
Berardi A; Evans DJ; Baldelli Bombelli F; Lomonossoff GP
Nanoscale; 2018 Jan; 10(4):1667-1679. PubMed ID: 29231944
[TBL] [Abstract][Full Text] [Related]
34. Pharmacology of a Plant Virus Immunotherapy Candidate for Peritoneal Metastatic Ovarian Cancer.
Omole AO; Affonso de Oliveira JF; Sutorus L; Steinmetz NF
ACS Pharmacol Transl Sci; 2024 Feb; 7(2):445-455. PubMed ID: 38357279
[TBL] [Abstract][Full Text] [Related]
35. CPMV-DOX delivers.
Aljabali AA; Shukla S; Lomonossoff GP; Steinmetz NF; Evans DJ
Mol Pharm; 2013 Jan; 10(1):3-10. PubMed ID: 22827473
[TBL] [Abstract][Full Text] [Related]
36. Chemical addressability of ultraviolet-inactivated viral nanoparticles (VNPs).
Rae C; Koudelka KJ; Destito G; Estrada MN; Gonzalez MJ; Manchester M
PLoS One; 2008 Oct; 3(10):e3315. PubMed ID: 18830402
[TBL] [Abstract][Full Text] [Related]
37. Radiation Therapy Combined with Cowpea Mosaic Virus Nanoparticle in Situ Vaccination Initiates Immune-Mediated Tumor Regression.
Patel R; Czapar AE; Fiering S; Oleinick NL; Steinmetz NF
ACS Omega; 2018 Apr; 3(4):3702-3707. PubMed ID: 29732445
[TBL] [Abstract][Full Text] [Related]
38. Systemic trafficking of plant virus nanoparticles in mice via the oral route.
Rae CS; Khor IW; Wang Q; Destito G; Gonzalez MJ; Singh P; Thomas DM; Estrada MN; Powell E; Finn MG; Manchester M
Virology; 2005 Dec; 343(2):224-35. PubMed ID: 16185741
[TBL] [Abstract][Full Text] [Related]
39. Cowpea Mosaic Virus Nanoparticle Vaccine Candidates Displaying Peptide Epitopes Can Neutralize the Severe Acute Respiratory Syndrome Coronavirus.
Ortega-Rivera OA; Shukla S; Shin MD; Chen A; Beiss V; Moreno-Gonzalez MA; Zheng Y; Clark AE; Carlin AF; Pokorski JK; Steinmetz NF
ACS Infect Dis; 2021 Nov; 7(11):3096-3110. PubMed ID: 34672530
[TBL] [Abstract][Full Text] [Related]
40. A Combination of Cowpea Mosaic Virus and Immune Checkpoint Therapy Synergistically Improves Therapeutic Efficacy in Three Tumor Models.
Wang C; Steinmetz NF
Adv Funct Mater; 2020 Jul; 30(27):. PubMed ID: 34366758
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
